Evidence map›Paper›PMID 37087107›Full record

ArticleJournal of neuropathology and experimental neurology2023

Association between APOE genotype and microglial cell morphology.

Courtney M Kloske, Mary D Gearon, Erica M Weekman, Colin Rogers, Ela Patel, Adam Bachstetter, Peter T Nelson, Donna M Wilcock

Open access · greenAbstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. ApoE lipidation state directs immunometabolic reprogramming of human microglia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Courtney M KloskeDepartment of Physiology, College of Medicine, Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Mary D GearonSanders-Brown Center on Aging, College of Medicine, University of Kentucky, Lexington, Kentucky, USA.
Erica M WeekmanDepartment of Physiology, College of Medicine, Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Colin RogersSanders-Brown Center on Aging, College of Medicine, University of Kentucky, Lexington, Kentucky, USA.
Ela PatelSanders-Brown Center on Aging, College of Medicine, University of Kentucky, Lexington, Kentucky, USA.
Adam BachstetterDepartment of Neuroscience, College of Medicine, Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Peter T NelsonDepartment of Pathology and Laboratory Medicine, College of Medicine, Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Donna M WilcockDepartment of Physiology, College of Medicine, Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
University of Kentucky · US

Funding

University of Kentucky Alzheimer's Disease Research CenterP30AG072946 · NIA · UNIVERSITY OF KENTUCKY · PI LINDA J VAN ELDIK · 2021 to 2026
$23.5M
University of Kentucky Alzheimer's Disease Core Center - Biomarker CoreP30AG028383 · NIA · UNIVERSITY OF KENTUCKY · PI SCHMITT, FREDERICK · 2006 to 2020
$23.3M
Therapeutic targeting of TREM2 for Alzheimer's diseaseRF1AG057754 · NIA · UNIVERSITY OF KENTUCKY · PI WILCOCK, DONNA M · 2018 to 2018
$1.9M
Assessing impaired neuroinflammation associated with Apolipoprotein E4F31AG069372 · NIA · UNIVERSITY OF KENTUCKY · PI KLOSKE, COURTNEY MARIE · 2020 to 2021
$74k
NIA NIH HHS F31 AG069372NIA NIH HHS P30 AG028383NIA NIH HHS P30 AG072946NIA NIH HHS RF1 AG057754
6 · The paper itself

Abstract

APOE is the largest genetic risk factor for late-onset Alzheimer disease (AD) with E4 conferring an increased risk for AD compared to E3. The ApoE protein can impact diverse pathways in the brain including neuroinflammation but the precise impact of ApoE isoforms on inflammation remains unknown. As microglia are a primary source of neuroinflammation, this study determined whether ApoE isoforms have an impact on microglial morphology and activation using immunohistochemistry and digital analyses. Analysis of ionized calcium-binding adaptor molecule 1 (Iba1) immunoreactivity indicated greater microglial activation in both the hippocampus and superior and middle temporal gyrus (SMTG) in dementia participants versus non-demented controls. Further, only an increase in activation was seen in E3-Dementia participants in the entire SMTG, whereas in the grey matter of the SMTG, only a diagnosis of dementia impacted activation. Specific microglial morphologies showed a reduction in ramified microglia in the dementia group. For rod microglia, a reduction was seen in E4-Control patients in the hippocampus whereas in the SMTG an increase was seen in E4-Dementia patients. These findings suggest an association between ApoE isoforms and microglial morphologies and highlight the importance of considering ApoE isoforms in studies of AD pathology.

Indexed as

Alzheimer DiseaseMicrogliaApolipoprotein E4Apolipoproteins EGenotypeHumansNeuroinflammatory DiseasesProtein IsoformsApolipoprotein E4Apolipoproteins EProtein IsoformsAlzheimer diseaseApoEMicrogliaNeuropathology

Identifiers

PMID37087107
PMCPMC10280358
OpenAlexW4366749218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.